Xanax can cause sedation, impaired coordination, memory problems and slowed reaction time, but those immediate effects are only one part of the risk profile. Alprazolam can also produce paradoxical behavioral changes, physical dependence and potentially dangerous withdrawal after repeated use. The most severe acute risks appear when it is combined with opioids, alcohol or other central nervous system depressants.

A useful side-effects guide should separate what can happen after one dose from what develops after weeks or months of exposure. It should also distinguish pharmaceutical alprazolam from a pill merely sold as Xanax, because counterfeit composition can produce a completely different toxicity pattern.

Xanax Side Effects at a Glance

Common neurologic effects Drowsiness, light-headedness, impaired coordination and cognitive slowing
Memory New-memory formation can be impaired
Behavior Disinhibition, irritability or paradoxical agitation can occur
Dependence Can develop with repeated prescribed or nonmedical use
Major interaction risk Opioids, alcohol and other CNS depressants
Emergency signs Profound unresponsiveness, abnormal breathing, major injury or severe confusion

Immediate Neurologic Effects: Sedation, Coordination, Reaction Time and Memory

Alprazolam enhances GABA-A-mediated inhibition in the brain. The same mechanism that reduces panic and autonomic arousal also slows neural systems involved in attention, coordination and reaction time. A patient can therefore experience genuine anxiety relief at the same time that driving, balance and rapid decision-making become less reliable.

Coordination problems do not require extreme intoxication. Mild ataxia can turn stairs, showers, nighttime bathroom trips and driving into injury risks. Older adults may be particularly vulnerable because the consequences of a fall are greater and because sedating medications are often layered with other prescriptions.

Memory impairment is another characteristic benzodiazepine effect. Alprazolam can interfere with formation of new memories after a dose. A person may appear awake enough to talk, shop online, send messages or take another pill and later have only partial recall. Anterograde memory impairment can make a patient’s own estimate of how much was taken unreliable even when the person is trying to report the event accurately.

Reaction time can remain impaired even when the person no longer describes themselves as sleepy. Tolerance may reduce the subjective sensation of sedation more than it restores normal psychomotor performance. Long-term users should not assume that familiarity with alprazolam makes activities such as driving risk-free.

The timing of side effects also matters. Peak effects occur after absorption, but repeated doses can overlap because alprazolam remains in the body for many hours. Someone who adds an extra dose during a stressful day can unintentionally move from therapeutic anxiolysis into clinically significant impairment.

Behavioral and Psychiatric Effects: Disinhibition, Confusion and Mood Risk

Most people expect Xanax to calm them, yet benzodiazepines can occasionally produce paradoxical reactions such as irritability, agitation, impulsivity or unusual disinhibition. These reactions become especially important when they appear after a dose increase, after alcohol use or in a person whose behavior changes abruptly from their baseline.

Disinhibition can create harm before a patient becomes profoundly sedated. The person may argue, drive, spend money, combine drugs or engage in risky behavior with reduced judgment. If memory is also impaired, the next-day account may substantially underestimate what occurred.

Confusion has a broad differential. Mild cognitive slowing can be a medication effect, but severe disorientation raises concern for excessive exposure, another sedative, head injury, infection or a counterfeit pill. A patient found confused after taking a loose “bar” should be evaluated differently from someone experiencing mild predictable drowsiness after a known pharmacy dose.

Depression and suicidality also need separate assessment. Alprazolam may be prescribed to people with comorbid mood disorders, and intoxication can reduce inhibition. Access to large quantities of a sedative can alter self-harm risk even when the benzodiazepine did not cause the underlying depression.

Persistent personality or cognitive change deserves clinical reassessment, including review of dose, other sedatives, sleep, psychiatric symptoms and alternative causes. Reassessment can identify excessive dose, interacting medications, sleep deprivation, untreated depression, polysubstance use or a treatment plan that no longer matches the patient’s needs.

Opioids, Alcohol and Other Sedatives: Why the Total Depressant Burden Matters

FDA’s alprazolam boxed warning states that combining benzodiazepines with opioids can cause profound sedation, respiratory depression, coma and death. Opioids suppress respiratory drive while alprazolam reduces arousal and can impair airway protection. The risk comes from the combination, not from a simple addition of two independent side-effect lists.

Alcohol creates another additive depressant state. Coordination worsens, memory formation can fail and judgment becomes less reliable. A person may take additional alprazolam while already intoxicated and later have no memory of the redosing.

Other benzodiazepines, zolpidem and other Z-drugs, sedating antihistamines, muscle relaxants and some psychiatric medications can contribute as well. The same alprazolam dose can produce a very different functional effect after another sedative is introduced.

Respiratory vulnerability matters too. Sleep apnea, chronic lung disease and severe obesity can make a sedative combination more consequential. Abnormal breathing or extreme difficulty waking after a medication change requires medical review because prescribed dose alone cannot rule out dangerous sedation, interaction or overdose.

Counterfeit pills magnify all of these uncertainties. If a supposed Xanax tablet contains fentanyl or another benzodiazepine, the expected interaction profile changes. Unexpected opioid-like toxicity should be treated as evidence that the actual exposure may not have been pharmaceutical alprazolam.

Medication timing can amplify this burden. A bedtime sedative may still be active when morning alprazolam is taken, or an evening opioid dose may overlap with a daytime benzodiazepine. Reviewing only drugs taken at the same clock time can therefore miss clinically important overlap.

Dependence, Tolerance and Withdrawal as Long-Term Alprazolam Risks

Physical dependence can develop during repeated benzodiazepine use, including prescribed treatment. Dependence means the nervous system has adapted to the presence of alprazolam and may become hyperexcitable when exposure falls. Physical dependence can occur during prescribed use and, by itself, does not establish addiction.

Tolerance can make the original dose feel less effective. Some patients respond by increasing dose or taking medication more frequently. But reduced perceived effect can also reflect worsening anxiety or interdose withdrawal, so dose escalation without reassessment can deepen dependence without solving the original problem.

Withdrawal can include anxiety, insomnia, tremor, sensory disturbances and cognitive symptoms. Severe reactions can include seizures, delirium, hallucinations and psychiatric instability. Alprazolam’s shorter action compared with some benzodiazepines can contribute to noticeable fluctuations between doses in dependent patients.

Once meaningful physical dependence develops, abrupt discontinuation can provoke severe withdrawal and should be avoided. Current FDA and ASAM guidance supports an individualized gradual reduction, with the pace adjusted to dose, duration, symptoms and clinical risk.

The separate Xanax Withdrawal guide owns tapering and withdrawal. Xanax Addiction addresses impaired control, craving and continued use despite harm.

Long-term adverse effects should also be judged by function. A patient who is increasingly unable to work, drive, remember conversations or sleep without medication may have a treatment problem even if the prescription remains within a labeled dose range. Function and dependence trajectory are more informative than dose alone.

When Side Effects Mean Emergency Care or a Change in the Treatment Plan

Profound unresponsiveness, slow or irregular breathing, repeated vomiting with reduced consciousness, cyanosis, major trauma or suspected intentional overdose requires urgent medical evaluation. A person who cannot be awakened normally needs emergency assessment, especially when breathing is slow, irregular or shallow or when another sedative or opioid may be involved.

Repeated falls, blackouts, unsafe driving, severe daytime sedation, escalating dose or paradoxical behavior are strong signals that the treatment plan needs reassessment. Emergency care depends on the immediate severity and symptoms. The dose may be excessive, a new interaction may be present or the person may be developing a misuse pattern.

If the tablet came from outside a licensed pharmacy, opioid-like symptoms raise additional concern for fentanyl exposure. Naloxone can reverse an opioid component but does not reverse alprazolam, so improvement after naloxone does not eliminate the need for further assessment.

The clinical goal is not automatic discontinuation. It is to decide whether alprazolam is still providing more benefit than risk, whether panic or anxiety is adequately treated, whether physical dependence has developed and whether all medication sources are reliable.

A good side-effect assessment therefore ends with a decision, not a list. The important questions are which effects are expected, which are impairing function, which suggest dangerous interaction, and which mean the entire benzodiazepine strategy should change.

Repeated side effects can also signal that the original indication needs to be revisited. Panic disorder, generalized anxiety, trauma, insomnia and substance use can change over time. A medication that was helpful during an acute period may no longer be the best long-term strategy if impairment or dependence now outweighs benefit.

Frequently Asked Questions About Xanax Side Effects

Can Xanax cause memory loss?

Yes. Benzodiazepines can impair formation of new memories.

Can Xanax affect driving?

Yes. Sedation, slowed reaction time and impaired coordination can affect driving safety.

Can Xanax make someone agitated?

Paradoxical agitation or disinhibition can occur in some patients.

Can prescribed Xanax cause dependence?

Yes. Physical dependence can occur without addiction.

What side effects are emergency signs?

Profound unresponsiveness, abnormal breathing, major trauma or severe confusion requires urgent evaluation.

Sources

Part of the Xanax (Alprazolam) resource silo

Continue exploring Xanax (Alprazolam)

Follow the topic in sequence or browse the full Xanax (Alprazolam) resource hub.

About This Article
Evidence-based sourcesSources verified August 17, 2026

Editorial standard

Rehabs.Today resource articles are written for educational and treatment-navigation purposes. For medical and drug-safety claims, we prioritize current primary or authoritative references such as FDA and DailyMed labeling, CDC, SAMHSA, NIH/NCBI resources, and peer-reviewed research when appropriate. Important limitations, uncertainty, and differences between population-level evidence and individual medical advice are stated where they matter.

How to use this information

This article provides general educational information. It is not a diagnosis, prescription, personalized taper, or substitute for advice from a physician, pharmacist, or other qualified healthcare professional. Do not start, stop, combine, or change a prescribed medication solely because of information on this page.

Emergency information

If someone cannot be awakened, is breathing slowly or abnormally, or may be experiencing an opioid overdose, seek emergency medical help immediately and give naloxone if it is available.

Treatment-directory transparency

Some Rehabs.Today articles link to treatment directories and provider resources. Those links are for navigation and do not replace independent medical assessment. Medical claims in the article should be evaluated from the cited evidence, not from whether a treatment provider is linked.